NO961031D0 - Fremgangsmåte til å drepe uönskede målceller - Google Patents

Fremgangsmåte til å drepe uönskede målceller

Info

Publication number
NO961031D0
NO961031D0 NO961031A NO961031A NO961031D0 NO 961031 D0 NO961031 D0 NO 961031D0 NO 961031 A NO961031 A NO 961031A NO 961031 A NO961031 A NO 961031A NO 961031 D0 NO961031 D0 NO 961031D0
Authority
NO
Norway
Prior art keywords
target cells
cells
procedure
unwanted target
killing unwanted
Prior art date
Application number
NO961031A
Other languages
English (en)
Norwegian (no)
Inventor
Oeystein Fodstad
Meng Yu Wang
Olav Engebraaten
Gunnar Kvalheim
Siri Juell
Original Assignee
Det Norske Radiumshospital Tum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Det Norske Radiumshospital Tum filed Critical Det Norske Radiumshospital Tum
Priority to NO961031A priority Critical patent/NO961031D0/no
Publication of NO961031D0 publication Critical patent/NO961031D0/no
Priority to DE69714775T priority patent/DE69714775T2/de
Priority to CA002248620A priority patent/CA2248620A1/en
Priority to US09/125,751 priority patent/US7198787B2/en
Priority to NZ331763A priority patent/NZ331763A/xx
Priority to RU98118574/14A priority patent/RU2182493C2/ru
Priority to PL97328804A priority patent/PL328804A1/xx
Priority to EP97916665A priority patent/EP0954329B1/en
Priority to IL12601497A priority patent/IL126014A0/xx
Priority to PCT/NO1997/000074 priority patent/WO1997033611A1/en
Priority to HU9901597A priority patent/HUP9901597A3/hu
Priority to BR9708049A priority patent/BR9708049A/pt
Priority to JP9532482A priority patent/JP2000507230A/ja
Priority to TR1998/01795T priority patent/TR199801795T2/xx
Priority to AT97916665T priority patent/ATE222122T1/de
Priority to KR1019980706983A priority patent/KR19990087546A/ko
Priority to AU25229/97A priority patent/AU710184B2/en
Priority to CN97194599A priority patent/CN1218411A/zh
Priority to SK1257-98A priority patent/SK125798A3/sk
Priority to NO984175A priority patent/NO984175D0/no
Priority to NZ336576A priority patent/NZ336576A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO961031A 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller NO961031D0 (no)

Priority Applications (21)

Application Number Priority Date Filing Date Title
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller
SK1257-98A SK125798A3 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins
IL12601497A IL126014A0 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins
HU9901597A HUP9901597A3 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immuno-toxins
US09/125,751 US7198787B2 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immuno-toxins
NZ331763A NZ331763A (en) 1996-03-13 1997-03-12 Immunotoxins comprising conjugates of antibodies and cell toxins, and use for killing cancer cells
RU98118574/14A RU2182493C2 (ru) 1996-03-13 1997-03-12 Метод уничтожения нежелательных клеток-мишеней
PL97328804A PL328804A1 (en) 1996-03-13 1997-03-12 Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins
EP97916665A EP0954329B1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with two immunotoxins
DE69714775T DE69714775T2 (de) 1996-03-13 1997-03-12 Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
PCT/NO1997/000074 WO1997033611A1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins
CA002248620A CA2248620A1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins
BR9708049A BR9708049A (pt) 1996-03-13 1997-03-12 Processo para matar células alvo indesejadas em uma população de células imunotoxinas para matar células uso das mesmas e kit para realizar o processo
JP9532482A JP2000507230A (ja) 1996-03-13 1997-03-12 望ましくない標的細胞の破壊方法
TR1998/01795T TR199801795T2 (xx) 1996-03-13 1997-03-12 �stenmeyen hedef h�crelerin �ld�r�lmeleri i�in y�ntem.
AT97916665T ATE222122T1 (de) 1996-03-13 1997-03-12 Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
KR1019980706983A KR19990087546A (ko) 1996-03-13 1997-03-12 하나 이상의 면역독소로 수집된 세포군에 있는 표적 세포를 괴사시키는 방법
AU25229/97A AU710184B2 (en) 1996-03-13 1997-03-12 Method for killing unwanted target cells
CN97194599A CN1218411A (zh) 1996-03-13 1997-03-12 杀死不想要的靶细胞的方法
NO984175A NO984175D0 (no) 1996-03-13 1998-09-10 Fremgangsmåte til å drepe målceller i höstede cellepopulasjoner med en eller flere immunotoksiner
NZ336576A NZ336576A (en) 1996-03-13 1999-07-05 Method of killing breast cancer cells with a combination of two immunotoxins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller

Publications (1)

Publication Number Publication Date
NO961031D0 true NO961031D0 (no) 1996-03-13

Family

ID=19899150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller

Country Status (18)

Country Link
US (1) US7198787B2 (ja)
EP (1) EP0954329B1 (ja)
JP (1) JP2000507230A (ja)
CN (1) CN1218411A (ja)
AT (1) ATE222122T1 (ja)
AU (1) AU710184B2 (ja)
BR (1) BR9708049A (ja)
CA (1) CA2248620A1 (ja)
DE (1) DE69714775T2 (ja)
HU (1) HUP9901597A3 (ja)
IL (1) IL126014A0 (ja)
NO (1) NO961031D0 (ja)
NZ (1) NZ331763A (ja)
PL (1) PL328804A1 (ja)
RU (1) RU2182493C2 (ja)
SK (1) SK125798A3 (ja)
TR (1) TR199801795T2 (ja)
WO (1) WO1997033611A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US7496291B2 (en) * 2006-03-21 2009-02-24 Hewlett-Packard Development Company, L.P. Method and apparatus for interleaved image captures
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
CA3069081C (en) 2008-09-20 2023-05-23 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
AU2009305550B2 (en) * 2008-10-17 2014-06-12 Dana-Farber Cancer Institute, Inc. MUC-1 cytoplasmic domain peptides as inhibitors of cancer
CN102665748A (zh) 2009-05-27 2012-09-12 达娜-法勃肿瘤研究所公司 使用muc1拮抗剂抑制炎症
CN102127148B (zh) * 2010-01-14 2013-04-03 中国农业科学院北京畜牧兽医研究所 血管内皮细胞表面决定簇部分多肽及其应用
ES2641877T3 (es) * 2011-05-06 2017-11-14 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Inmunotoxina recombinante dirigida a mesotelina
CN107748256B (zh) * 2017-10-11 2020-04-14 厦门骁科码生物科技有限公司 一种循环肿瘤细胞的液体活检检测方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219411A (en) 1978-09-18 1980-08-26 California Institute Of Technology Cell sorting apparatus
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4510244A (en) 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4920061A (en) 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4752569A (en) 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
US5019497A (en) 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4710472A (en) 1985-09-25 1987-12-01 The United States Of America As Represented By The Secretary Of The Navy Magnetic separation device
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
EP0241042A3 (en) 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4857452A (en) 1986-12-04 1989-08-15 E. I. Du Pont De Nemours And Company Assay for carcinoma of breast, colon and ovary
US5194300A (en) 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
US5322678A (en) 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
FR2638848B1 (fr) 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
DE68919715T2 (de) 1988-12-28 1995-04-06 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
WO1990010692A1 (en) 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia
US5081030A (en) 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
DE3919923A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
JPH05503632A (ja) * 1989-12-14 1993-06-17 スローン　―　ケターリング・インスティチュート・フォー・キャンサー・リサーチ モノクローナル抗体ｍ１９５の超可変領域の治療的使用およびその構築
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
GB9007966D0 (en) 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
JPH05107249A (ja) 1991-02-04 1993-04-27 Toyobo Co Ltd リガンド・レセプター反応の高感度検出法
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
AU2115092A (en) 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
CA2131090A1 (en) 1992-03-20 1993-09-21 Peter Leonard Grant Method and apparatus for the analysis of biological material
US5422277A (en) 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
WO1994002016A1 (en) * 1992-07-28 1994-02-03 Steven Kessler Methods for positive immunoselection of stem cells
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
ES2123063T3 (es) 1992-09-14 1999-01-01 Stanford Res Inst Int Marcadores convertidores al alza para ensayos biologicos y otros mediante tecnicas de excitacion laser.
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
AUPN214095A0 (en) 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
SK125798A3 (en) 1999-05-07
WO1997033611A1 (en) 1997-09-18
AU710184B2 (en) 1999-09-16
US7198787B2 (en) 2007-04-03
BR9708049A (pt) 1999-07-27
CA2248620A1 (en) 1997-09-18
US20020151689A1 (en) 2002-10-17
PL328804A1 (en) 1999-02-15
IL126014A0 (en) 1999-05-09
HUP9901597A3 (en) 2000-06-28
EP0954329A1 (en) 1999-11-10
TR199801795T2 (xx) 1998-12-21
CN1218411A (zh) 1999-06-02
RU2182493C2 (ru) 2002-05-20
DE69714775D1 (de) 2002-09-19
AU2522997A (en) 1997-10-01
ATE222122T1 (de) 2002-08-15
HUP9901597A2 (hu) 1999-08-30
DE69714775T2 (de) 2003-04-24
JP2000507230A (ja) 2000-06-13
NZ331763A (en) 2000-01-28
EP0954329B1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
BR9912662A (pt) Melhoria de função cardìaca por transplante de célula de ramo mesenquimal
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
NO961031D0 (no) Fremgangsmåte til å drepe uönskede målceller
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
NO20035637D0 (no) Karbonmonoksyd forbedrer resultatene av vev og organ transplantater og undertrykker apoptose
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
DE69940507D1 (de) Biotechnisch erzeugte gefässprothese für die implantation
DK1019082T4 (da) Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
IT1299175B1 (it) Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
DE69935999D1 (de) Methoden zur introduktion heterologer zellen in fische
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
DE60039863D1 (de) Verwendung von zytokinen und mitogenen zur inhibierung von pathologischen immunantworten
DE69737455D1 (de) Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben
WO2003029432A3 (en) Human mesenchymal progenitor cell
NO984175L (no) FremgangsmÕte til Õ drepe mÕlceller i h°stede cellepopulasjoner med en eller flere immunotoksiner
EP1728857A3 (en) Liver tissue source
MX9706725A (es) Mezclas enzimaticas definidas, novedosas para obtener celulas y para tratamientos de heridas.
WO2000066784A3 (en) Growth hormone-regulatable brown adipose tissue genes, corresponding proteins and uses thereof
KR920000943A (ko) 시험관내 조직의 생존력 및 증식능 측정을 위한 천연-상태 방법 및 시스템
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
MX9710304A (es) Composiciones para la preparacion de cuero.
RU98102969A (ru) Способ трансплантации органов и тканей